DCs targeted in vivo with an anti-DEC205 chimeric antibody to deliver myelin oligodendrocyte glycoprotein prevented subsequent experimental autoimmune encephalomyelitis [42]. Here, MOG is linked to experimental autoimmune encephalomyelitis.